Resveratrol's antioxidant properties: dosage and does it really slow down aging

In 2003, David Sinclair from Harvard published a study in Nature showing that resveratrol extends the lifespan of yeast by 70%. The media announced the discovery of the "elixir of youth in red wine." Since then, resveratrol has become one of the most marketed antioxidants on the market. The truth, as often is the case, is more complex. The mechanism works. Sirtuins are activated. Mice have extended lifespans with high doses. But in humans – clinical studies are small, inconsistent, and far from confirming anti-aging effects. This article describes what resveratrol can really do, what is hype, and how to use it rationally.

KEY INFORMATION
• The bioavailability of resveratrol from oral supplements is about 1% – it is metabolized by gut bacteria and liver enzymes into less active derivatives (Cottart et al., 2014, Mol Nutr Food Res).
• A glass of red wine (150 ml) contains 0.2–1 mg of resveratrol – a supplemental dose of 250 mg corresponds to 125–1250 glasses of wine.
• Documented clinical effects in humans: antioxidant, potentially metabolic (insulin sensitivity). Anti-aging and lifespan extension effects – unproven.
• Interaction: resveratrol inhibits CYP3A4 and CYP2C9 – increasing the concentration of warfarin and some statins. Consultation is advised when using anticoagulants.

What is resveratrol and where does it come from?

Resveratrol is a stilbenoid – a class of polyphenolic plant compounds. It is produced by plants as a defense mechanism against fungi, UV radiation, and environmental stress – it belongs to the group of phytotoxins (phytoalexins). Major sources: grapes (skin, especially red varieties like Pinot Noir), blueberries, raspberries, peanuts, Japanese knotweed (Polygonum cuspidatum – the most common raw material for supplements). There are two main forms: trans-resveratrol (biologically active) and cis-resveratrol (less active). Supplements should contain trans-resveratrol.

Scientific interest in resveratrol began with the so-called "French paradox" – low cardiovascular mortality in France despite a diet rich in saturated fats, which was attributed to the consumption of red wine. This hypothesis was popular in the 1990s, but later analyses indicate many confounding variables (Mediterranean diet, physical activity, lifestyle).

Our observations: Resveratrol is an emblematic example of a supplement that looks great in studies on model organisms but poorly translates to clinical studies in humans. This phenomenon is common in aging biology – yeast and C. elegans nematodes are too simple organisms to draw conclusions about human aging. Nevertheless, resveratrol as an antioxidant is real – just don't expect "immortality" from it.

Sirtuins – the key to the anti-aging mechanism

Sirtuins (SIRT1–7) are a family of deacetylases and NAD+-dependent ADP-ribosyltransferases. They regulate metabolism, DNA repair, autophagy, stress response, and circadian rhythm. SIRT1 – the best-studied – is activated by caloric restriction and physical exercise. Activation of SIRT1 deacetylates FOXO (stress response transcription factors), PGC-1α (mitochondrial biogenesis), and p53 (DNA repair). The effect: better mitochondrial function, slower cellular senescence.

Resveratrol activates SIRT1 directly through allosteric binding to the catalytic domain (Sinclair lab data, Nature 2003) and indirectly through activation of AMPK and increased NAD+. In simple organisms (yeast, C. elegans, Drosophila), this translated into significant lifespan extension. In mice on a high-fat diet, resveratrol improved metabolism and endurance, although it did not always extend lifespan. Cottart et al. (2014, Molecular Nutrition and Food Research) conducted a meta-analysis of clinical studies in humans and showed that resveratrol did not improve mortality or quality of life markers in large cohorts – although some metabolic biomarkers improved in the short term.

What resveratrol can really do – a review of clinical evidence

Antioxidant and anti-inflammatory action – in small RCTs, resveratrol reduced markers of oxidative stress (8-OHdG, MDA, F2-isoprostanes) and inflammation (CRP, IL-6, TNF-α). The effects were consistent, although the effect size was moderate. A meta-analysis by Liu et al. (2015, Journal of Nutritional Biochemistry) of 17 RCTs confirmed significant reductions in CRP and IL-6 at doses of 100–500 mg/d.

Insulin sensitivity and metabolism – several RCTs showed improved insulin sensitivity (HOMA-IR) and reduced fasting glucose with resveratrol at 500–2000 mg/d in patients with diabetes or prediabetes. The effects were smaller and less consistent than with berberine. Cardiovascular system – improvement in vascular elasticity (FMD – flow-mediated dilation) in some RCTs, although results are mixed. No reduction in cardiovascular events was confirmed.

Brain and cognitive functions – studies suggest an impact on neuroprotection (through SIRT1, AMPK, and modulation of beta-amyloid aggregation), but clinical RCTs in humans with Alzheimer's disease yielded inconsistent results. Research is ongoing.

Bioavailability – the biggest problem with resveratrol

Resveratrol is notorious for its poor bioavailability. After oral administration, about 70–75% is absorbed from the small intestine, but almost immediately metabolized in the intestinal wall and liver to glucuronides and sulfates – forms with significantly lower biological activity. The final bioavailability of unchanged trans-resveratrol in the blood: about 1%. Walle et al. (2004, Drug Metabolism and Disposition) demonstrated in PK that after administering 25 mg of trans-resveratrol, its serum concentration was minimal – sulfated metabolites predominated.

How to improve bioavailability? Piperine (extract from black pepper) – inhibits glucuronidation in the intestine and liver, increasing the bioavailability of resveratrol 2–3 times. Micronization (particles below 2 µm) – increases the absorption surface area. Liposomal or nanoencapsulated form – in studies shows 4–10 times higher bioavailability. Trans-resveratrol vs. cis – always choose the trans- form, as it is biologically active. Forms with rodkin (red wine extract) contain a natural polyphenolic matrix, but concentrations are low.

Dosage, safety, and interactions

Dosage in clinical studies in humans: 100–2000 mg/d of trans-resveratrol. Practical supplementation range: 250–500 mg/d for antioxidant and metabolic effects. Higher doses (1000–2000 mg/d) have been studied in metabolic and neurodegenerative diseases – supervision is required. Take with a meal containing fats (resveratrol is lipophilic) or with piperine for better absorption.

Safety profile: at 250–1000 mg/day, resveratrol is generally safe in studies up to 3 months. At higher doses (1500–2000 mg/day), gastrointestinal discomfort (nausea, diarrhea) may occur. Long-term safety (beyond a year) – limited data. Paradox: at very high doses, resveratrol may act pro-oxidatively (an effect called 'hermes' – low antioxidant doses, high pro-oxidative).

Drug interactions: resveratrol inhibits CYP3A4, CYP2C9, and P-glycoprotein. It may increase the concentration of warfarin (risk of bleeding), some statins, and antiarrhythmic drugs. With anticoagulants – mandatory consultation with a doctor. It may also slightly enhance the effects of antihypertensive medications.

An honest summary – what to know before purchasing

Resveratrol is a supplement with an interesting mechanism, real antioxidant action, and poor bioavailability, which has shown spectacular effects in studies on simple organisms, but yielded moderate and inconsistent results in clinical studies on humans. This does not mean it is worthless – it acts as an antioxidant, may improve insulin sensitivity and inflammatory markers. However, the marketing of 'slowing aging' and 'elixir of youth' is unjustified based on current data.

Who might be interested in resveratrol? Individuals seeking a natural antioxidant with metabolic and anti-inflammatory effects, on a diet high in processed foods or in states of increased oxidative stress. It makes no sense to buy resveratrol if the main motivation is the belief that it 'slows aging' – there is insufficient clinical data in humans for this effect.

If you are interested in activating sirtuins and anti-aging pathways, a more documented route is NMN (nicotinamide mononucleotide) or NR (nicotinamide riboside) – direct precursors of NAD+, which raise NAD+ levels more effectively than resveratrol. But that is a topic for a separate article.

Resveratrol in the prevention of cancer and cardiovascular diseases

In vitro and animal studies show strong anti-proliferative and pro-apoptotic effects of resveratrol on cancer cells – mechanisms include inhibition of NF-κB, activation of p53, inhibition of cyclin D1, and modification of estrogen metabolism (potential significance in breast cancer prevention). However, clinical studies in humans are in the preliminary stages. Resveratrol is being studied as an adjunct to chemotherapy (phase I/II), but there is still no data confirming its effectiveness in cancer prevention in humans.

Cardiovascular system – besides effects on the lipid profile, resveratrol exhibits anti-aggregatory effects (inhibits platelet aggregation by inhibiting thromboxane A2 and COX-1) and vasodilatory effects (activation of NOS – nitric oxide synthase, increased NO). Several small RCTs have shown improvement in FMD (flow-mediated dilation – a marker of endothelial function) with resveratrol at 150–500 mg/d. Clinical significance is unclear, as the studies were short-term and small, but the mechanism is biologically justified as a complement to a Mediterranean diet rich in polyphenols.

Pterostilbene – the active form of resveratrol with higher bioavailability

Pterostilbene is a natural analog of resveratrol found in blueberries and grapes, with a key structural difference: two methoxy groups instead of hydroxyl groups increase lipophilicity and resistance to intestinal and hepatic metabolism. The bioavailability of pterostilbene is about 80% (vs. about 1% for resveratrol). The mechanisms of action are similar to resveratrol – activation of SIRT1, antioxidant and anti-inflammatory properties – but at significantly lower supplemental doses.

Clinical studies with pterostilbene are fewer than with resveratrol, but preliminary results are promising. Dosage: 50–150 mg/d of pterostilbene showed effects comparable to 500 mg/d of resveratrol in metabolic studies. For those looking to achieve the effects of resveratrol with better bioavailability, pterostilbene is an interesting alternative, although the availability of ready-made preparations in Poland is limited. It is increasingly found in formulations combined with resveratrol.

How to choose a good resveratrol supplement – a practical buying guide

The resveratrol supplement market is saturated with products of varying quality. Key parameters to consider when choosing: form of resveratrol (always trans-resveratrol, never cis), percentage standardization of the extract (minimum 98% trans-resveratrol), source of raw material (extract from Japanese knotweed Polygonum cuspidatum is the industrial standard, grapes as a raw material are rarer and more expensive) and the presence of bioavailability enhancers.

Bioavailability is a key issue when choosing a form. Standard trans-resveratrol in capsules has about 1% bioavailability – this means that from a 500 mg tablet, about 5 mg of the active compound enters circulation. Preparations with piperine (extract from black pepper, bioperine) increase bioavailability 2–3 times by inhibiting CYP1A1/1A2 and UDP-glucuronosyltransferase in the intestine. Liposomal and micronized forms achieve 10–20 times higher bioavailability than standard tablets, but are more expensive. If the budget is limited, choose a supplement with piperine instead of a more expensive liposomal form.

It is worth considering combined preparations: resveratrol + quercetin (antioxidant synergy and CYP inhibition), resveratrol + NMN or NR (both raise NAD+ through different pathways – resveratrol activates SIRT1, NMN provides substrate), resveratrol + OPC (oligomeric proanthocyanidins from grape seeds) – a natural combination with strong effects on the cardiovascular system. Avoid preparations with resveratrol in the presence of foods high in phytic acid (bran, flax seeds) consumed simultaneously – they may reduce the absorption of polyphenols.

Frequently asked questions

Does resveratrol really slow aging?

Mechanistically activates sirtuins and AMPK, which extended the lifespan of yeast and mice. In humans – there is no clear evidence. Cottart et al. (2014) showed that resveratrol did not improve mortality or quality of life in large cohorts. Antioxidant and metabolic effects are documented, but anti-aging effects in humans are unproven.

How to dose resveratrol?

Supplementation range: 250–500 mg/d of trans-resveratrol with a meal containing fats. Higher doses (1000–2000 mg/d) are used in metabolic studies. Choose forms with piperine or micronized trans-resveratrol for better bioavailability – standard tablets have about 1% bioavailability.

How much resveratrol is in red wine?

A typical glass (150 ml) of Pinot Noir – about 0.5–2 mg of resveratrol. A supplemental dose of 250 mg = 125–500 glasses of wine. Drinking wine for resveratrol makes no sense – the hype of the 'French paradox' was based on imperfect epidemiological data.

Does resveratrol have documented health benefits?

Yes: reduction of oxidative stress (8-OHdG, MDA), lowering of CRP and IL-6 (Liu 2015, meta-analysis of 17 RCTs), potential improvement in insulin sensitivity in some RCTs. Cardiovascular and cognitive effects – mixed, require further research.

Is resveratrol safe?

At 250–1000 mg/day – generally safe in short-term studies. At higher doses: gastrointestinal discomfort. Interaction with CYP3A4 and CYP2C9: may increase the concentration of warfarin and statins. Mandatory consultation when taking anticoagulants. Long-term data beyond one year – limited.

Sirtuins and resveratrol – what is the anti-aging mechanism?

Sirtuins (SIRT1–7) are deacetylases that regulate DNA repair, autophagy, and stress response. SIRT1 is activated by caloric restriction and exercise. Resveratrol may activate SIRT1 through allosteric binding and increased NAD+. In model organisms, this extended lifespan. In mammals, results are inconsistent.

This article is for informational and educational purposes and does not replace consultation with a physician. If you are pregnant, breastfeeding, taking medications, or have chronic conditions, consult the use of supplements or herbs with a specialist.

Author: Michał Waluk · Published: 2026-05-04 · Updated: 2026-05-04